Physician profile
Daniel Saunders
NPI 1235118753
$1,092.71
in general payments reported to CMS, 2019-2025
12 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $24.16 · 2021: $207 · 2022: $116 · 2023: $242 · 2024: $245 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $277.20 | 2020-2024 | Fixos, Easyfuse, Variax |
| Musculoskeletal Transplant Foundation INC. | $177.40 | 2019-2022 | |
| Organogenesis INC. | $153.73 | 2023-2025 | Puraply, Apligraf, Cygnus Dual |
| Nevro Corp. | $129.36 | 2023 | Senza |
| Forthright Medical - Az, LLC | $74.18 | 2024 | |
| Abbott Laboratories | $66.16 | 2024-2025 | Jot Dx, Aveir |
| Polynovo North America LLC | $63.49 | 2024 | Novosorb Btm |
| Orthofix Medical, INC. | $60.39 | 2019-2023 | Physio-Stim |
| Smith+Nephew, INC. | $48.29 | 2020-2023 | Regranex, Collagenase Santyl |
| Solventum Corporation | $18.20 | 2025 | Activ.A.C. |
| Horizon Therapeutics Plc | $15.15 | 2019 | |
| Medela LLC | $9.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.